News for 'US Generics'

Is Adani a Modi Crony?

Is Adani a Modi Crony?

Rediff.com11 Apr 2023

This State-corporate 'cooperation' didn't begin with the arrival of the Modi government.
Many of the big licences, contracts, and even environmental clearances for the Adani group had come in the UPA's time, points out Shekhar Gupta.

3 Indian pharma cos recall products in US market

3 Indian pharma cos recall products in US market

Rediff.com24 Apr 2022

Leading drug firms Aurobindo Pharma, Sun Pharma and Jubilant are recalling different products in the US market for various reasons, as per the latest enforcement report by the US Food and Drug Administration (USFDA). While Aurobindo Pharma is recalling Cyanocobalamin Injection, which is used to treat and prevent lack of vitamin B12, Mumbai-based Sun Pharma is recalling a drug used to increase the production of natural tears in eyes. Similarly, Jubilant Cadista is recalling a drug which is used to treat different inflammatory conditions.

Quality perceptions hobble Jan Aushadi drugs

Quality perceptions hobble Jan Aushadi drugs

Rediff.com10 Oct 2018

Large pharmaceutical firms feel that if the quality parameters and assurance levels are brought up to the level of branded generics, then Jan Aushadhi medicines would find it difficult to retain their affordability.

Bhumi Gyaan: How Women Can Get What They Want

Bhumi Gyaan: How Women Can Get What They Want

Rediff.com15 Mar 2023

'Every woman should believe she is a lady killer because that's the only way she can gain the confidence to achieve whatever she wants in life.'

No, Friends is Not The Best Sitcom Ever!

No, Friends is Not The Best Sitcom Ever!

Rediff.com14 Jul 2023

'The pride of the devoted Seinfeld fan is that he happens to love a show that doesn't take his love for granted, so that even on repeat viewings he is never really sure what directions an episode might take,' observes Sreehari Nair.

'A Lot Of Demand For Niche Talent'

'A Lot Of Demand For Niche Talent'

Rediff.com11 Aug 2022

'Generic skills are in abundance, but technological advancements have left staple skills redundant.' 'It is why employers are now looking for alternate sources of hiring -- deploying gig workers, looking at Tier 2 and Tier 3 cities for relevant talent.'

IUML member moves resolution in RS seeking Sachar report implementation

IUML member moves resolution in RS seeking Sachar report implementation

Rediff.com10 Feb 2023

A private member resolution seeking that the government implement the recommendations of the Sachar Committee report and other reports that have discussed the educational and social backwardness of Muslims and enact a legislation for the prevention of atrocities against minorities was moved in the Rajya Sabha on Friday.

Projects that harm Joshimath should be stopped: Badrinath head priest

Projects that harm Joshimath should be stopped: Badrinath head priest

Rediff.com15 Jan 2023

Talking to PTI, he said the development works should be implemented by protecting the lives of the people.

9 Lies Told About Skincare

9 Lies Told About Skincare

Rediff.com9 Feb 2023

There seems to be a barrage of age-old blunders that people tend to commit in the name of skincare, says dermatologist Dr Batul Patel, director, The Bombay Skin Clinic.

HC questions govt over poor infra for security at Subramanian Swamy's house

HC questions govt over poor infra for security at Subramanian Swamy's house

Rediff.com31 Oct 2022

The court was informed by the central government that a security review of Swamy's private house, where he would be residing after vacating the government-allotted bungalow, has been undertaken.

Your Tax Queries Answered

Your Tax Queries Answered

Rediff.com23 Dec 2022

Anil Rego, CEO, Right Horizons, answers your personal income tax queries.

Budget: Sitharaman promises 80 lakh houses under PMAY in 2022-23

Budget: Sitharaman promises 80 lakh houses under PMAY in 2022-23

Rediff.com1 Feb 2022

Finance Minister Nirmala Sitharaman on Tuesday announced allocation of whopping Rs 48,000 crore for completion of 80 lakh houses under the Pradhan Mantri Awas Yojana (PMAY), both rural and urban, during the next fiscal year. In her budget speech, the minister said: "In 2022-23, 80 lakh houses will be completed for the identified eligible beneficiaries of PM Awas Yojana, both rural and urban. Rs 48,000 crore is allocated for this purpose." The Centre would work with states for reduction of time required for all land and construction related approvals, for promoting affordable housing for middle-class and Economically Weaker Sections (EWS) in urban areas, she said.

Lupin sells Japan arm to Unison for Rs 3,702 cr

Lupin sells Japan arm to Unison for Rs 3,702 cr

Rediff.com12 Nov 2019

The company will now focus on specialty products in Japan; it is open to inorganic opportunities, especially in India.

IIT-Madras is India's Top University

IIT-Madras is India's Top University

Rediff.com15 Jul 2022

Seven Indian Institutes of Technology -- IIT-Madras, IIT-Bombay, IIT-Delhi, IIT-Kanpur, IIT-Kharagpur, IIT-Roorkee and IIT-Guwahati -- figured in the top 10 in the overall rankings.

The Best Of Yash Chopra On OTT

The Best Of Yash Chopra On OTT

Rediff.com11 May 2023

Deepa Gahlot lists the most popular Yash Chopra films -- the ones he directed, not produced (yes, so that means no DDLJ) -- that can be watched on OTT.

Merck to license oral Covid drug Molnupiravir to 5 Indian firms

Merck to license oral Covid drug Molnupiravir to 5 Indian firms

Rediff.com27 Apr 2021

Drug firm MSD has decided to enter into voluntary licensing agreements for investigational oral antiviral drug candidate 'Mmolnupiravir', which is being studied for the treatment of Covid-19, with Indian drug firms Sun Pharma, Cipla, Dr Reddy's, Emcure Pharma and Hetero Labs, its Indian arm said on Tuesday.

2 reasons why drug sales are in poor health

2 reasons why drug sales are in poor health

Rediff.com11 May 2019

Overall slowdown in the economy and growing volumes of unbranded generic medicines in the domestic market are behind poor sales.

Personal info of Akasa Air's passengers leaked, airline informs CERT-In

Personal info of Akasa Air's passengers leaked, airline informs CERT-In

Rediff.com29 Aug 2022

Personal information such as name, gender, email address and phone numbers of some Akasa Air passengers has been leaked to "unauthorised individuals", the airline stated on Sunday. India's newest carrier said it self-reported this incident to Indian Computer Emergency Response Team CERT-In, which is the government-authorised nodal agency tasked to deal with matters of this nature. However, Akasa Air asserted that there was no "intentional hacking attempt, but that the situation was reported by a research expert through a journalist for which we are grateful".

Commission revises long form for M&As, changes effective from May 1

Commission revises long form for M&As, changes effective from May 1

Rediff.com5 Apr 2022

Companies planning merger and acquisition (M&A) will have to disclose the extent of "complementary linkages" among them and their impact on the market. This comes under the revised reporting requirements of the Competition Commission of India (CCI). The changes will take effect on May 1. Entities may also have to provide market-facing data of the past five years with respect to their market size, the market share of the parties, and also that of the competitors, along with customers and suppliers.

Long Term Investor? Small-Cap Funds Best Bet

Long Term Investor? Small-Cap Funds Best Bet

Rediff.com14 Sep 2022

Over longer periods of three, five and 10 years, small-cap funds have rewarded their investors handsomely.

How to identify fake vaccine: Centre issues parameters

How to identify fake vaccine: Centre issues parameters

Rediff.com5 Sep 2021

The Centre has shared a set of parameters with all states and UTs to enable service providers and monitoring teams under the national COVID-19 vaccination programme to identify any fake COVID-19 vaccines so that they are not administered in the country.

India-centric plans help Dr Reddy's outperform pharma market

India-centric plans help Dr Reddy's outperform pharma market

Rediff.com27 Dec 2019

In November, DRL registered growth of 28 per cent year-on-year (YoY), which was the highest among peers and double that of the industry growth (14.5 per cent).

'Downside In Markets May Be Limited'

'Downside In Markets May Be Limited'

Rediff.com13 Oct 2022

'India seems to be on a relatively better wicket compared to other emerging markets.'

Artificial intelligence gets a realtime local edge

Artificial intelligence gets a realtime local edge

Rediff.com18 Jul 2022

When computing moved to the cloud, it brought a lot of advantages of managing data at scale. Computation of large sets of information sourced from several locations allowed experts to interpret data at scale with flexibility. Artificial intelligence (AI) played a critical role in helping understand patterns which could lead to business insights. In the new scenario, using AI in the cloud is not enough anymore.

Why cold wave across US is good news for Indian drug cos

Why cold wave across US is good news for Indian drug cos

Rediff.com12 Mar 2019

Companies such as Cadila Healthcare, Lupin, and Natco, which sell generic versions of flu medication in the US market, are likely to benefit.

AMU's Governance Structure Is Democratic, Not Divine

AMU's Governance Structure Is Democratic, Not Divine

Rediff.com18 Mar 2023

These self-appointed well-wishers of AMU are basically for the control or police model of university governance. They have no faith whatsoever in the democratic functioning of the universities, observes Faizan Mustafa, former dean, Faculty of Law, and Registrar, Aligarh Muslim University.

PE/VC investments in pharma cos cross $1 bn mark

PE/VC investments in pharma cos cross $1 bn mark

Rediff.com6 Oct 2020

Fund managers said investors remained positive on the pharma manufacturing activity in India, which further strengthened during the Covid-19 period, on account of restrictions imposed on pharma imports from China.

Why Cipla is a good bet for long-term investment

Why Cipla is a good bet for long-term investment

Rediff.com15 Dec 2020

While Covid-related sales may come down going ahead, analysts expect the company's domestic sales to outperform the market, led by the chronics portfolio, which accounts for 55 per cent of sales.

It's official, Fryums won't attract any GST

It's official, Fryums won't attract any GST

Rediff.com3 Nov 2021

The Appellate Authority for Advance Rulings (AAAR) of Gujarat has held that papad fryums would not attract any goods and services tax (GST) as they are similar to traditional round papads in all respects. In this connection, the appellate authority modified the ruling of the authority for advance rulings (AAR), which had ruled that Fryums would attract 18 per cent GST. The AAAR held that Fryums is a brand and not a generic name of the product, Harpreet Singh, partner, indirect taxes at KPMG in India said while explaining the order.

Why investors are regretting giving Gland Pharma IPO a miss

Why investors are regretting giving Gland Pharma IPO a miss

Rediff.com24 Nov 2020

Gland Pharma, promoted by China's Fosun, has extended its gains, is up 40 per cent since its listing.

RRR And KGF: When Money Gives You Roots

RRR And KGF: When Money Gives You Roots

Rediff.com18 Aug 2022

'I believe it's not the success of RRR or KGF that we must actually investigate but what makes these two films our marquee events,' argues Sreehari Nair.

Biocon Biologics Plan Molecule Launch Every 1-2 Years

Biocon Biologics Plan Molecule Launch Every 1-2 Years

Rediff.com17 Aug 2022

'The tie-up with Serum Institute Life Sciences brings to the table their strengths in manufacturing and also their vaccine portfolio.'

Only high-risk contacts of confirmed cases need to get tested: ICMR

Only high-risk contacts of confirmed cases need to get tested: ICMR

Rediff.com10 Jan 2022

The ICMR Advisory on Purposive Testing Strategy for COVID-19 also said individuals undertaking inter-state domestic travels do not need to get tested either.

Vikram Vedha Review: Whistle-Worthy Film

Vikram Vedha Review: Whistle-Worthy Film

Rediff.com30 Sep 2022

A screenplay and superstar in perfect tandem, it doesn't get better than this, applauds Sukanya Verma.

Govt may now cap prices of antibiotics

Govt may now cap prices of antibiotics

Rediff.com7 Oct 2019

The intention of the government is to cap prices of drugs that are essential and which the public widely uses.

Modi arrives in Jammu hamlet amid tight security

Modi arrives in Jammu hamlet amid tight security

Rediff.com24 Apr 2022

Amid multi-tier security, Prime Minister Narendra Modi on Sunday will dedicate India's first 'carbon neutral panchayat' to the nation apart from inaugurating and laying foundation stone of development projects worth over Rs 20,000 crore to give fillip to speedy development of Jammu and Kashmir.

Modi to inaugurate projects worth Rs 20k cr in Jammu tomorrow

Modi to inaugurate projects worth Rs 20k cr in Jammu tomorrow

Rediff.com23 Apr 2022

Seeking to develop and rejuvenate 75 water bodies in every district of the country, the prime minister will launch a new initiative named 'Amrit Sarovar', it said.

Sun Pharma's Dilip Shanghvi takes 99% pay cut

Sun Pharma's Dilip Shanghvi takes 99% pay cut

Rediff.com2 Aug 2019

As on July 31, the valuation of his shareholding in the company stood at Rs 9,830 crore.

9 Signs You're Dating A Cheater

9 Signs You're Dating A Cheater

Rediff.com8 Aug 2022

Feeling forced or creeped out is not only a red flag, but a strong sign of possible deception. Trust your gut!

J&J's loss may be good news for Indian pharmas

J&J's loss may be good news for Indian pharmas

Rediff.com1 Nov 2018

Dr Reddy's, Glenmark, Wockhardt have lined up alternatives for Zytiga